tiprankstipranks
MDxHealth (MDXH)
NASDAQ:MDXH

MDxHealth (MDXH) Income Statement

138 Followers

MDxHealth Income Statement

Last quarter (Q4 2023), MDxHealth's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, MDxHealth's net income was $―. See MDxHealth’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 11.15M$ 70.19M$ 37.05M$ 22.24M$ 18.46M$ 11.79M
Cost of Revenue
$ 4.93M$ 26.26M$ -17.84M$ -11.68M$ 10.52M$ 11.93M
Gross Profit
$ 6.22M$ 43.93M$ 19.22M$ 10.56M$ 7.94M$ -144.00K
Operating Expense
$ 18.15M$ 70.80M$ 63.82M$ 40.74M$ 35.06M$ 43.02M
Operating Income
$ -11.93M$ -26.87M$ -44.60M$ -30.17M$ -27.12M$ -43.17M
Net Non Operating Interest Income Expense
$ -1.70M$ -16.23M$ 533.13K$ 11.00K$ -1.42M$ -502.00K
Other Income Expense
--$ -559.00K$ -1.15M--
Pretax Income
$ -13.63M$ -43.10M$ -44.04M$ -29.00M$ -28.66M$ -43.67M
Tax Provision
$ -129.00K$ 1.00K--$ 0.00$ -575.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -13.50M$ -43.10M$ -44.04M$ -29.00M$ -28.66M$ -43.10M
Basic EPS
$ -0.08-$ -0.28$ -0.24$ -0.34$ -0.69
Diluted EPS
$ -0.08-$ 0.28$ -0.24$ -0.34$ -0.69
Basic Average Shares
$ 172.36M-$ 158.66M$ 2.20M$ 83.20M$ 62.58M
Diluted Average Shares
$ 172.36M-$ 157.30M$ 120.84M$ 83.20M$ 62.58M
Dividend Per Share
---$ 0.85--
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 23.08M$ 97.06M$ 45.99M$ 29.06M$ 45.58M$ 54.95M
Net Income From Continuing And Discontinued Operation
$ -13.50M$ -43.10M$ -44.04M$ -29.00M$ -28.66M$ -43.10M
Normalized Income
$ -13.50M$ -31.68M--$ -28.54M$ -43.10M
Interest Expense
$ 1.76M---$ 1.23M$ 318.00K
EBIT
$ -11.87M$ -24.76M$ -44.36M$ -29.23M$ -27.43M$ -43.36M
EBITDA
$ -10.57M$ -17.90M$ -39.45M$ -26.20M$ -24.10M$ -39.94M
Currency in USD

MDxHealth Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis